Relationship between Patients’ Baseline Characteristics and Survival Benefits in Immunotherapy-Treated Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
Table 3
Differences in overall survival associated with immunotherapy in age by subgroups.
Participants, no.
Pooled HR (95% CI) for ICI vs. controlled therapies